ANDA 75733, held by Ani Pharms. Clobetasol Propionate.
As of Nov 16, 2026, ANDA 75733 (Clobetasol Propionate (Emollient)), held by Ani Pharms, was first approved by FDA on Aug 22, 2001, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 22, 2001 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clobetasol Propionate (Emollient)0.05% ยท cream;topical | Clobetasol Propionate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters